<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Weight management</title>
            <link>https://medicalxpress.com/overweight-obesity-news/</link>
            <language>en-us</language> 
            <description>Latest health news and information about Weight Management</description>

                            <item>
                    <title>The connection between high-fat ketogenic diets and weight loss</title>
                    <description>Ketogenic diets have attracted enormous attention for their purported health benefits, particularly their ability to promote weight loss. Despite their popularity, studies investigating the composition of these high-fat, low-carbohydrate regimens have produced inconsistent results. Some studies have found substantial metabolic benefits, while others have found little or no improvement.</description>
                    <link>https://medicalxpress.com/news/2026-11-high-fat-ketogenic-diets-weight.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 10:20:10 EST</pubDate>
                    <guid isPermaLink="false">news714304922</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/keto-diet-3.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Sugar made by gut bacterium may help the body burn visceral fat</title>
                    <description>Scientists have discovered that a sugar produced by a gut bacterium can increase energy burning in visceral fat—the harmful fat that accumulates around internal organs—while reducing weight gain and improving metabolic health, offering a potential new approach to tackling obesity.</description>
                    <link>https://medicalxpress.com/news/2026-11-sugar-gut-bacterium-body-visceral.html</link>
                    <category></category>
                    <pubDate>Thu, 19 Nov 2026 06:40:08 EST</pubDate>
                    <guid isPermaLink="false">news714291914</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/sugar-made-by-gut-bact.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Semaglutide may improve eating disorder symptoms and body image in adults seeking obesity treatment</title>
                    <description>Adults receiving semaglutide for obesity treatment experienced greater improvements in several measures of disordered eating, eating disorder symptoms and body image concerns compared with participants receiving placebo, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania. The study was published in the International Journal of Eating Disorders.</description>
                    <link>https://medicalxpress.com/news/2026-11-semaglutide-disorder-symptoms-body-image.html</link>
                    <category></category>
                    <pubDate>Wed, 18 Nov 2026 07:00:01 EST</pubDate>
                    <guid isPermaLink="false">news714204360</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/semaglutide-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Large and very small waist sizes linked to heightened death risk across weight range</title>
                    <description>Both large and very small waist sizes are linked to a heightened risk of death across a broad range of body weights, finds a large study of more than 17 million adults, published online in the Journal of Epidemiology &amp; Community Health.</description>
                    <link>https://medicalxpress.com/news/2026-11-large-small-waist-sizes-linked.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Nov 2026 18:30:09 EST</pubDate>
                    <guid isPermaLink="false">news714070321</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/small-waist.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>GLP-1 weight-loss drugs linked to inadequate intake of key nutrients in some people</title>
                    <description>Drugs taken to suppress appetite, such as Wegovy and Mounjaro, are associated with inadequate intakes of key nutrients and energy in some people, finds a small exploratory study published in the journal BMJ Nutrition Prevention &amp; Health.</description>
                    <link>https://medicalxpress.com/news/2026-11-glp-weight-loss-drugs-linked.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Nov 2026 18:30:06 EST</pubDate>
                    <guid isPermaLink="false">news714054841</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/person-taking-suppleme.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Tirzepatide moves more than half of treated teens below obesity threshold, new clinical trial reports</title>
                    <description>Tirzepatide (Zepbound) is a once-weekly injectable medication that hits two targets at once. This dual-action drug mimics the effects of two natural gut hormones in the body—glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Working together, these hormones keep blood sugar in check, slow the movement of food through the gut and signal the brain about fullness, which helps manage appetite and food intake.</description>
                    <link>https://medicalxpress.com/news/2026-11-tirzepatide-teens-obesity-threshold-clinical.html</link>
                    <category></category>
                    <pubDate>Tue, 17 Nov 2026 08:30:04 EST</pubDate>
                    <guid isPermaLink="false">news714126561</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/tirzepatide-moved-more.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Ending Medicaid coverage for weight-loss drugs linked to sharp drop in GLP-1 use</title>
                    <description>Medicaid prescriptions for weight loss–approved GLP-1 medications fell sharply after four states ended coverage of the drugs, according to a new study led by researchers at the University of Pittsburgh. The findings, published in JAMA, demonstrate how state coverage decisions can have an immediate and substantial effect on access to these medications.</description>
                    <link>https://medicalxpress.com/news/2026-11-medicaid-coverage-weight-loss-drugs.html</link>
                    <category></category>
                    <pubDate>Mon, 16 Nov 2026 11:00:09 EST</pubDate>
                    <guid isPermaLink="false">news714033754</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/glp-1-medications.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>RNA switch lets drugs control gene therapy protein production</title>
                    <description>Bioengineers at the University of California San Diego have developed a technology that allows drugs to control when cells produce therapeutic proteins, which could potentially make gene therapies safer and more adaptable for treating chronic diseases.</description>
                    <link>https://medicalxpress.com/news/2026-11-rna-drugs-gene-therapy-protein.html</link>
                    <category></category>
                    <pubDate>Fri, 13 Nov 2026 16:20:06 EST</pubDate>
                    <guid isPermaLink="false">news713800922</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-rna-switch-could-m.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>GLP-1s often contain untested additive combinations, study finds</title>
                    <description>Use of GLP-1 receptor agonist medications (GLP-1s) has skyrocketed in recent years, and many people are using &quot;compounded&quot; GLP-1 products: medicines that include GLP-1s as well as other active substances, some of which are not regulated by the FDA. A new study found that compounded GLP-1s now make up a large majority of weight-loss medicines, commonly containing vitamin B12 analogs that have not been tested for safety in combination with GLP-1s.</description>
                    <link>https://medicalxpress.com/news/2026-11-glp-1s-untested-additive-combinations.html</link>
                    <category></category>
                    <pubDate>Fri, 13 Nov 2026 16:00:01 EST</pubDate>
                    <guid isPermaLink="false">news713800264</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/glp-1-medications.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New clinical definition of obesity could help target care more effectively, saving time and money</title>
                    <description>The traditional way of assessing whether someone is overweight using body mass index (BMI) may fail to capture whether excess body fat is harmful and could be supplemented with a second measure when assessing patients, a new UCL study suggests.</description>
                    <link>https://medicalxpress.com/news/2026-11-clinical-definition-obesity-effectively-money.html</link>
                    <category></category>
                    <pubDate>Wed, 11 Nov 2026 16:40:02 EST</pubDate>
                    <guid isPermaLink="false">news713631781</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/body-mass-index.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New clinical definition outperforms BMI in diagnosing obesity</title>
                    <description>A new diagnostic definition of obesity outperforms body mass index (BMI) in identifying differences in health and prognosis, including mortality risk, according to a large international study published in Nature.</description>
                    <link>https://medicalxpress.com/news/2026-11-clinical-definition-outperforms-bmi-obesity.html</link>
                    <category></category>
                    <pubDate>Wed, 11 Nov 2026 11:00:40 EST</pubDate>
                    <guid isPermaLink="false">news713524262</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/bmi-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Effective obesity treatments reach few eligible teens, study finds</title>
                    <description>Despite the arrival of powerful new anti-obesity medications and growing evidence supporting weight-loss surgery for adolescents, the vast majority of eligible teens are receiving neither treatment, according to a new study from Ann &amp; Robert H. Lurie Children&#039;s Hospital of Chicago published in JAMA Pediatrics.</description>
                    <link>https://medicalxpress.com/news/2026-11-effective-obesity-treatments-eligible-teens.html</link>
                    <category></category>
                    <pubDate>Wed, 11 Nov 2026 07:20:11 EST</pubDate>
                    <guid isPermaLink="false">news713600628</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2024/weight-loss-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Resistance training key to maintaining muscle function during GLP-1 weight loss, study shows</title>
                    <description>A study has revealed that resistance (weight) training not only preserves lean and muscle mass but also increases strength in people taking weight-loss medication. Published in Nature Medicine, the Tirzepatide and Resistance Exercise (T-REx) study is the first to show the effects of combining a GLP-1 medicine and resistance training on body composition, muscle mass, strength and a range of cardiovascular health measures.</description>
                    <link>https://medicalxpress.com/news/2026-11-resistance-key-muscle-function-glp.html</link>
                    <category></category>
                    <pubDate>Tue, 10 Nov 2026 14:00:14 EST</pubDate>
                    <guid isPermaLink="false">news713537161</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/hand-weights-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Night owls who eat late may face higher health risks</title>
                    <description>A new study led by UTHealth Houston identified a link between late-night eating and sleeping habits, gut health and metabolic disease, offering new insights into why some individuals with obesity may face a risk of inflammation and related health problems. The study was published in iScience and led by Faraz Bishehsari, M.D., Ph.D., professor and director of the Gastroenterology Research Center in the Department of Internal Medicine at McGovern Medical School at UTHealth Houston.</description>
                    <link>https://medicalxpress.com/news/2026-11-night-owls-late-higher-health.html</link>
                    <category></category>
                    <pubDate>Tue, 10 Nov 2026 13:40:05 EST</pubDate>
                    <guid isPermaLink="false">news713536802</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/eating-and-sleeping-la.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Semaglutide may lower fetal oxygen levels, sheep study suggests</title>
                    <description>They&#039;re the blockbuster drugs transforming weight loss, helping millions of people to shed unwanted kilograms. But while medications such as Ozempic and Wegovy may also improve women&#039;s chances of becoming pregnant, what happens to their unborn babies if they continue to take the drugs during pregnancy?</description>
                    <link>https://medicalxpress.com/news/2026-11-semaglutide-fetal-oxygen-sheep.html</link>
                    <category></category>
                    <pubDate>Tue, 10 Nov 2026 04:40:01 EST</pubDate>
                    <guid isPermaLink="false">news713507434</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/pregnant-5.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Why obesity affects males and females differently</title>
                    <description>University of California, Riverside, scientists have an explanation for why males and females respond differently to obesity. They report in PNAS Nexus that certain immune cell populations in fat tissue may protect against obesity-related inflammation while others may contribute to harmful metabolic changes. They found these immune cells, called eosinophils and traditionally associated with asthma and allergies, behave differently in males and females.</description>
                    <link>https://medicalxpress.com/news/2026-11-obesity-affects-males-females-differently.html</link>
                    <category></category>
                    <pubDate>Mon, 09 Nov 2026 09:40:06 EST</pubDate>
                    <guid isPermaLink="false">news713439001</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/overweight-people.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials</title>
                    <description>For people with painful knee osteoarthritis (OA) who are overweight or have obesity, everyday activities such as walking, climbing stairs and standing up from a chair can be difficult. In two Northwestern University–led Phase III clinical trials involving more than 1,000 participants combined, those taking the highest dose of retatrutide, a new experimental weight-loss injectable drug, lost about one-quarter of their body weight on average.</description>
                    <link>https://medicalxpress.com/news/2026-11-experimental-weight-loss-drug-eases.html</link>
                    <category></category>
                    <pubDate>Sun, 08 Nov 2026 11:30:01 EST</pubDate>
                    <guid isPermaLink="false">news713177942</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/painful-knee.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
